Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes
- PMID: 17311420
- DOI: 10.1021/bi602396x
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes
Abstract
Botulinum neurotoxins (BoNTs) elicit flaccid paralysis through cleavage of SNARE proteins within peripheral neurons. There are seven serotypes of the BoNTs, termed A-G, which differ in the SNARE protein and/or site that is cleaved. BoNTs are single-chain toxins that comprise an N-terminal zinc metalloprotease domain that is disulfide linked to the C-terminal translocation/receptor binding domain. SV2 and synaptotagmin have been identified as receptors for BoNT serotypes A and B, respectively. Using affinity chromatography, BoNTs A and B were observed to bind synaptic vesicle protein complexes in synaptosome lysates. Tandem LC-MS/MS identified SV2, synaptotagmin I, synaptophysin, vesicle-associated membrane protein 2 (VAMP2), and the vacuolar proton pump as components of the BoNT-receptor complex. Density gradient analysis showed that BoNT serotypes A and B exhibited unique interactions with the synaptic vesicle protein complexes. The association of BoNT serotypes A and B with synaptic vesicle protein complexes implicates a physiological role for protein complexes in synaptic vesicle biology and provides insight into the interactions of BoNT and neuronal receptors.
Similar articles
-
Association of botulinum neurotoxins with synaptic vesicle protein complexes.Toxicon. 2009 Oct;54(5):570-4. doi: 10.1016/j.toxicon.2009.01.040. Epub 2009 Apr 9. Toxicon. 2009. PMID: 19362106 Free PMC article. Review.
-
Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.Biochemistry. 2013 Jun 4;52(22):3930-8. doi: 10.1021/bi4003502. Epub 2013 May 17. Biochemistry. 2013. PMID: 23647335
-
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.Nature. 2006 Dec 21;444(7122):1092-5. doi: 10.1038/nature05387. Epub 2006 Dec 13. Nature. 2006. PMID: 17167421
-
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.Biochemistry. 2009 Jun 23;48(24):5631-41. doi: 10.1021/bi9002138. Biochemistry. 2009. PMID: 19476346 Free PMC article.
-
[Mechanisms of action of botulinum toxins and neurotoxins].Ann Dermatol Venereol. 2009 May;136 Suppl 4:S73-6. doi: 10.1016/S0151-9638(09)74531-4. Ann Dermatol Venereol. 2009. PMID: 19576489 Review. French.
Cited by
-
A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.PLoS Pathog. 2018 May 2;14(5):e1007048. doi: 10.1371/journal.ppat.1007048. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29718991 Free PMC article.
-
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.PLoS Pathog. 2011 Mar;7(3):e1002008. doi: 10.1371/journal.ppat.1002008. Epub 2011 Mar 31. PLoS Pathog. 2011. PMID: 21483489 Free PMC article.
-
Receptor and substrate interactions of clostridial neurotoxins.Toxicon. 2009 Oct;54(5):550-60. doi: 10.1016/j.toxicon.2008.12.027. Epub 2009 Mar 4. Toxicon. 2009. PMID: 19268493 Free PMC article. Review.
-
Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.J Biol Chem. 2011 Apr 29;286(17):15067-72. doi: 10.1074/jbc.M111.224493. Epub 2011 Mar 4. J Biol Chem. 2011. PMID: 21378164 Free PMC article.
-
SV2 mediates entry of tetanus neurotoxin into central neurons.PLoS Pathog. 2010 Nov 24;6(11):e1001207. doi: 10.1371/journal.ppat.1001207. PLoS Pathog. 2010. PMID: 21124874 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical